FACCHETTI, GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 7.240
AS - Asia 6.870
EU - Europa 6.730
SA - Sud America 688
AF - Africa 169
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 5
Totale 21.746
Nazione #
US - Stati Uniti d'America 6.994
SG - Singapore 2.213
CN - Cina 1.986
IT - Italia 1.924
GB - Regno Unito 1.316
DE - Germania 699
SE - Svezia 629
HK - Hong Kong 575
BR - Brasile 539
RU - Federazione Russa 499
VN - Vietnam 467
IN - India 451
FR - Francia 346
IE - Irlanda 253
BD - Bangladesh 238
FI - Finlandia 192
KR - Corea 190
NL - Olanda 182
JP - Giappone 179
DK - Danimarca 156
ES - Italia 156
CA - Canada 146
ID - Indonesia 142
TR - Turchia 124
CH - Svizzera 58
PL - Polonia 58
AT - Austria 56
MX - Messico 52
CI - Costa d'Avorio 50
PK - Pakistan 45
IR - Iran 41
AR - Argentina 39
UA - Ucraina 39
BE - Belgio 37
AU - Australia 36
TW - Taiwan 36
PH - Filippine 30
CO - Colombia 27
ZA - Sudafrica 27
IQ - Iraq 26
CZ - Repubblica Ceca 25
CL - Cile 24
EC - Ecuador 21
MA - Marocco 20
RO - Romania 17
IL - Israele 16
VE - Venezuela 16
EG - Egitto 15
MY - Malesia 14
SA - Arabia Saudita 14
TH - Thailandia 14
DZ - Algeria 13
SC - Seychelles 13
AZ - Azerbaigian 12
CR - Costa Rica 12
GR - Grecia 11
AL - Albania 10
UZ - Uzbekistan 10
HU - Ungheria 9
PT - Portogallo 9
BG - Bulgaria 8
LT - Lituania 8
NZ - Nuova Zelanda 8
PE - Perù 8
JM - Giamaica 7
NO - Norvegia 7
NP - Nepal 7
PA - Panama 6
JO - Giordania 5
LU - Lussemburgo 5
PY - Paraguay 5
TN - Tunisia 5
UY - Uruguay 5
BO - Bolivia 4
HN - Honduras 4
KE - Kenya 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
BZ - Belize 3
CM - Camerun 3
EE - Estonia 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
GT - Guatemala 3
HR - Croazia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MV - Maldive 3
NG - Nigeria 3
PS - Palestinian Territory 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
IM - Isola di Man 2
Totale 21.714
Città #
Singapore 1.335
Southend 1.078
Dallas 917
Ashburn 768
Milan 673
Hong Kong 451
San Jose 443
Chandler 415
Fairfield 337
Beijing 309
Council Bluffs 290
Hefei 236
Dublin 220
Seattle 213
Wilmington 212
Frankfurt am Main 209
Los Angeles 208
Houston 194
Ann Arbor 182
New York 158
Woodbridge 158
Princeton 155
Cambridge 150
Bengaluru 149
Ho Chi Minh City 146
Santa Clara 142
Helsinki 117
Hanoi 116
Munich 111
Lauterbourg 109
Jakarta 107
Moscow 103
Seoul 98
Guangzhou 91
Tokyo 90
Buffalo 84
Bologna 82
Nanjing 75
Boardman 62
Dearborn 60
Columbus 54
Redwood City 54
Des Moines 52
Istanbul 52
Phoenix 52
Shanghai 52
Abidjan 50
Toronto 50
Rome 48
São Paulo 45
Naples 44
Padova 43
Berlin 40
Medford 38
The Dalles 38
Shenzhen 37
Hangzhou 36
Florence 35
Kolkata 35
Nuremberg 35
London 34
Jinan 33
Karlsruhe 33
Orem 33
Cangzhou 32
Rio de Janeiro 30
Brussels 29
Lappeenranta 29
Bergamo 28
Vienna 28
Brescia 27
Chicago 27
San Diego 27
Tianjin 27
Turku 27
Changsha 26
Fremont 26
Roxbury 25
Atlanta 24
Turin 24
Wuhan 24
Saint Petersburg 23
Shenyang 23
Warsaw 23
Amsterdam 22
Boston 22
Fuzhou 22
Da Nang 21
Haiphong 21
Taipei 20
Madrid 19
Montreal 19
Pohang 19
Zaragoza 19
Central District 18
Kent 18
Mumbai 18
Zhengzhou 18
Münster 17
Basingstoke 16
Totale 12.914
Nome #
An in vivo active 1,2,5-oxadiazole Pt(II) complex : a promising anticancer agent endowed with STAT3 inhibitory properties 420
Amphiphilic Pt(II) complexes for in vivo bioimaging applications 418
Synthesis of new dithiolethione and methanethiosulfonate systems endowed with pharmaceutical interest 414
Artificial metalloenzymes based on vancomycin for stereoselective catalysis in aqueous media 367
Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in PtII complexes on human carcinoma cell lines: A comparative study with cisplatin 315
Luminescent amphiphilic Pt(II) complexes and their assemblies 298
Efficient methodology to produce a duloxetine precursor using whole cells of Rhodotorula rubra 297
Self-assembly in vivo: imaging and reactivity 294
Simple 1,3-diamines and their application as ligands in ruthenium(ii) catalysts for asymmetric transfer hydrogenation of aryl ketones 292
Conventional and non-conventional catalytic systems for the asymmetric reduction of cyclic imines 287
Fluorinated dichloride platinum complexes: a new series of promising anticancer agents against orphan tumors 286
Sensitivity of mesenchymal stromal cells to a new imidazole-based cationic Pt(II) complex with high in vitro anticancer activity 283
Novel 3,3-disubstituted oxindole derivatives. Synthesis and evaluation of the anti-proliferative activity 279
Water soluble Ir-complexes for ECL signal amplification in pathogens detection 278
Ruthenium(II) complexes bearing (NNN) ligand : catalytic evaluation of different solvent-mediated coordination modes 276
Self-assembled complex promotes cell proliferation and stem cell self-renewal through redox signaling in in vivo model 276
Novel platinum agents and mesenchymal stromal cells for thoracic malignancies : state of the art and future perspectives 273
Antiproliferative effects of chalcones on T cell acute lymphoblastic leukemia‐derived cells: Role of PKCβ 272
Monofunctional Pt(II) complexes based on 8-aminoquinoline: synthesis and pharmacological characterization 268
Cascade Reaction by Chemo- and Biocatalytic Approaches to Obtain Chiral Hydroxy Ketones and anti 1,3-Diols 266
“In situ” Activation of Racemic RuII Complexes: Separation of trans and cis Species and Their Application in Asymmetric Reduction 263
Electrochemiluminescent multinuclear metal complexes for diagnostics 257
Anticancer platinum(II) complexes bearing N-heterocycle rings 256
Exploring the copper binding ability of Mets7 hCtr‐1 protein domain and His7 derivative: An insight in Michael addition catalysis 254
Alternative Strategy to Obtain Artificial Imine Reductase by Exploiting Vancomycin/D-Ala-D-Ala Interactions with an Iridium Metal Complex 248
Malignant Pleural Mesothelioma : State of the art and advanced cell therapy 246
Cytotoxic platinum(II) complexes bearing N-heterocycle rings as novel theranostic agents 245
Enantioselective transfer hydrogenation of aryl ketones: synthesis and 2D-NMR characterization of new 8-amino-5,6,7,8-tetrahydroquinoline Ru(II)-complexes 244
Vancomycin-Iridium (III) Interaction: An Unexplored Route for Enantioselective Imine Reduction 244
Uptake-release by MSCs of a cationic platinum(II) complex active in vitro on human malignant cancer cell lines 242
Luminescent self-assemblies of Pt(II) complexes in vivo 242
Catalytic Applications for Heavy Metals Bio-recovery 238
Evaluation of chemical diversity of biotinylated chiral 1,3-diamines as a catalytic moiety in artificial imine reductase 237
Anticancer platinum‑drug delivered by mesenchymal stromal cells improves its activity on glioblastoma 235
Luminescent water-soluble cycloplatinated complexes: structural, photophysical, electrochemical and chiroptical properties 231
Synthesis and crystallographic structure of nickel(0) carbonyl complex with Bitianp, an atropoisomeric diphosphine 231
Enhancing Pt (IV) Complexes Anticancer Activity Upon Encapsulation in Stimuli Responsive Nanocages 229
One-pot catalytic strategies for the efficient and enantioselective synthesis of L-Carnosine 229
In vitro anticancer activity evaluation of new cationic platinum(II) complexes based on imidazole moiety 227
8-Amino-5,6,7,8-tetrahydroquinoline in iridium(iii) biotinylated Cp* complex as artificial imine reductase 225
Cationic platinum(II) complexes active in vivo as anticancer drugs 222
Promising antiproliferative platinum(II) complexes based on imidazole moiety: synthesis, evaluation in HCT-116 cancer cell line and interaction with Ctr-1 Met-rich domain 220
8-Amino-5,6,7,8-Tetrahydroquinolines as Ligands in Iridium(III) Catalysts for the Reduction of Aryl Ketones by asymmetric transfer hydrogenation (ATH) 216
Cationic Pt(II) complex based on 8-aminoquinoline: in vitro activity against human glioblastoma 213
8-Amino-5,6,7,8-tetrahydroquinolines as ligands in iridium(III) catalysts for the reduction of aryl ketones by asymmetric transfer hydrogenation (ATH) 207
Ni²⁺ and Cu²⁺ Biosorption by EPS-Producing Serratia plymuthica Strains and Potential Bio-Catalysis of the Organo–Metal Complexes 203
The mesenchymal stromal cells increased the activity on glioblastoma of a new delivered anticancer platinum-drug 201
One-pot reactions in catalysis: a valuable tool for the synthesis of enantiopure intermediates for pharmaceutical applications 192
Hybrid Catalysts from Copper Biosorbing Bacterial Strains and Their Recycling for Catalytic Application in the Asymmetric Addition Reaction of B2(pin)2 on α,β-Unsaturated Chalcones 192
Chemo- and biocatalytic strategies to obtain phenylisoserine, lateral chain of taxol by asymmetric reduction 186
Diastereoselectivity and catalytic activity in ruthenium complexes chiral at the metal centre 186
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase‑B 186
Nonabsorbable Iron(III) binding polymers : Synthesis and evaluation of the chelating properties 185
Combined chemical and biocatalytic approach for asymmetric one-pot reactions 183
Amphiphilic Pt(II) complex for in vivo imaging applications 183
Mets7 motif peptides in coordinative Cu(I) complexes: application in asymmetric Henry reaction 183
New sp3 diphosphine-based rhodium catalysts for the asymmetric conjugate addition of aryl boronic acids to 3-azaarylpropenones 182
STAT3 direct inhibitors: from MD77 to AC33 180
New Mets7 motif metallopeptide catalysts for Cu(I)-catalyzed asymmetric Henry reaction 180
In Vitro Activity of Monofunctional Pt-II Complex Based on 8-Aminoquinoline against Human Glioblastoma 179
Aminoquinoline-based Ruthenium catalyst for reduction of ketones by hydrogen transfer 178
Highly efficient morpholine-based organocatalysts for the 1,4-addition reaction between aldehydes and nitroolefins: an unexploited class of catalysts 177
"In situ" activation of racemic Ru(II) complexes : separation of trans and cis species and their application in asymmetric reduction 174
Asymmetric Hydrogenation of 1-aryl substituted-3,4-Dihydroisoquinolines with Iridium Catalysts Bearing Different Phosphorus-Based Ligands 173
An oxadiazole Pt(II) complex with promising in vivo antitumor activity 172
Synthesis and anticancer activity of cyclometalated Pt(II) neutral complexes containing curcumin as a bioactive ancillary ligand 169
Biological Properties of New Chiral 2-Methyl-5,6,7,8-tetrahydroquinolin-8-amine-based Compounds 169
Recycling of copper contaminants from wastewater as new hybrid catalysts for the synthesis of valuable pharmaceutical intermediates 164
Oxadiazole Pt(II) complexes: promising STAT3 inhibitors in cancer therapy 164
A new series of fluorinated dichloride platinum complexes as promising anticancer agents against orphan tumors 163
Alizarin as a selective carrier in cytotoxic Pt(II) complexes toward Triple Negative Breast Cancer (TNBC) 161
Cytotoxic performances of new anionic cyclometalated Pt(II) complexes bearing chelated O^O ligands 160
A new artificial reductase based on the D-Ala-D-Ala/Vancomycin supramolecular interaction and its applications in the enantioselective reduction of cyclic imines 158
Sintesi stereoselettiva di ammine cicliche di interesse farmaceutico mediata da catalizzatori ibridi 157
New Platinum(II) complexes in STAT3 inhibition: a promising tool for anticancer therapy 156
Asymmetric Hydrogenation vs Transfer Hydrogenation in the Reduction of Cyclic Imines 152
Catalytic strategies for the synthesis of carnosine derivatives 151
Chiral 8-Amino-5,6,7,8-tetrahydroquinoline Derivatives in Metal Catalysts for the Asymmetric Transfer Hydrogenation of 1-Aryl Substituted-3,4-dihydroisoquinolines as Alkaloids Precursors 149
Exploitation of Dimeric Cyclic Cysteine as Helix Inducer in Ultra‐Short Peptides for Cu(II)‐Catalyzed Asymmetric Michael Addition on Chalcones 147
New 1,2,5-oxadiazole Pt(II)complex endowed with STAT3 inhibitory properties as promising anticancer agent 146
New hybrid imine reductases based on Vancomycin for the asymmetric reduction of cyclic imines in aqueous buffer 146
Fluorine activation of promising platinum compounds as anticancer drugs against orphan tumors 144
Ctr-1 Mets7 motif inspiring new peptide ligands for Cu(i)-catalyzed asymmetric Henry reactions under green conditions 143
Sensitivity of human glioblastoma to a new monofunctional PT-II compex based on 8-aminoquinoline 143
Double approaches for obtaining an asymmetric one-pot addition/reduction reaction 142
Curcumin-based ionic Pt(ii) complexes: antioxidant and antimicrobial activity 142
Asymmetric reduction of cyclic imines by a new hybrid catalyst based on an iridium-vancomycin system 139
Asymmetric one-pot reaction matching chemical and biocatalytic approaches 136
New fluorinated platinum compounds as promising anticancer warriors against orphan tumors 135
A novel series of monofunctional Pt(II) complexes framed on 8-aminoquinoline: synthesis and antiproliferative studies 133
Hybrid Metal Catalysts as Valuable Tools in Organic Synthesis: An Overview of the Recent Advances in Asymmetric C–C Bond Formation Reactions 130
New rhodium-sp3 diphosphine catalytic systems for the asymmetric addition of aryl boronic acids to azaarenes 129
Reproducible Ala-Gly oligomerization catalyzed by the natural Borate colemanite in prebiotic conditions 126
One-pot chemoenzymatic synthesis of enantiopure aryl- and alkyl-azaarenes pharmaceutical intermediates 124
Theragnostic neutral Pt(II) complexes based on 8-aminoquinoline skeleton 124
Breakable nanomaterials to allow hair coloring with natural dyes 123
New antiproliferative platinum(II) complexes based on imidazol moiety 123
The Challenging Treatment of Cisplatin-Resistant Tumors: State of the Art and Future Perspectives 122
Cytotoxic Pt(ii) complexes containing alizarin: a selective carrier for DNA metalation 122
Amphiphilic Pt(II) complex for in vivo imaging applications 121
Totale 20.748
Categoria #
all - tutte 64.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.889


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021194 0 0 0 0 0 0 0 0 0 0 92 102
2021/20221.858 166 92 81 132 123 139 151 114 245 115 140 360
2022/20231.998 258 184 189 154 195 295 68 146 192 49 175 93
2023/20241.541 73 121 87 103 270 90 124 132 44 96 195 206
2024/20254.005 169 324 209 432 333 240 239 365 206 329 413 746
2025/20269.050 844 764 1.465 820 878 623 1.091 421 864 511 769 0
Totale 22.594